Journal of Interventional Cardiology / 2022 / Article / Tab 2 / Research Article
Primary Percutaneous Coronary Intervention with High-Bolus Dose Tirofiban: The FASTER (Favorite Approach to Safe and Effective Treatment for Early Reperfusion) Multicenter Registry Table 2 Clinical characteristics.
n 472 Age (years) 61.5 ± 11.2 Male gender (n , %) 391 (83) Weight (Kg) 78.8 ± 14.6 History of smoking (n , %) 287 (61) Diabetes mellitus (n , %) 79 (17) Hypertension (n , %) 247 (53) Dyslipidemia (n , %) 208 (45) Previous myocardial infarction (n , %) 48 (10) Previous TIA/stroke (n , %) 18 (4) Previous PCI (n , %) 57 (12) Previous CABG (n , %) 12 (3) STEMI location (n , %) Anterior 217 (46) Nonanterior 253 (54) Killip class 3-4 12 (2.5) Heart rate (bpm) 77 ± 18 Systolic blood pressure (mmHg) 134 ± 27 Hemoglobin (g/dl) 14.5 ± 2.5 Hematocrit (%) 42.5 ± 5.8 GFR (ml/min) 82.1 ± 23.5